Open-label, pilot study of the safety and clinical effects of rituximab in patients with rheumatoid arthritis-associated interstitial pneumonia - Matteson, E L; Bongartz, T; Ryu, J H; Crowson, C S; Hartman, T; Dellaripa, P F (Open J Rheumatol Autoimmune Dis, 2012)